Cancer & Metabolism

Papers
(The median citation count of Cancer & Metabolism is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition102
GCN2-SLC7A11 axis coordinates autophagy, cell cycle and apoptosis and regulates cell growth in retinoblastoma upon arginine deprivation65
The classification of obesity based on metabolic status redefines the readmission of non-Hodgkin’s lymphoma—an observational study48
FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma42
Ketomimetic nutrients remodel the glycocalyx and trigger a metabolic defense in breast cancer cells36
Magnetospirillum magneticum triggers apoptotic pathways in human breast cancer cells31
Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies31
Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina response31
ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma31
Circulating metabolome landscape in Lynch syndrome26
Glycemic status, insulin resistance, and mortality from lung cancer among individuals with and without diabetes25
Autofluorescence imaging of endogenous metabolic cofactors in response to cytokine stimulation of classically activated macrophages25
Steatohepatitis-induced vascular niche alterations promote melanoma metastasis21
Correction: Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells21
Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stress21
CYP19A1 regulates chemoresistance in colorectal cancer through modulation of estrogen biosynthesis and mitochondrial function19
Disrupting Na+ ion homeostasis and Na+/K+ ATPase activity in breast cancer cells directly modulates glycolysis in vitro and in vivo18
ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors18
Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomics17
Characterizing OXPHOS inhibitor-mediated alleviation of hypoxia using high-throughput live cell-imaging17
DHODH and cancer: promising prospects to be explored16
Long-acting Erwinia chrysanthemi, Pegcrisantaspase, induces alternate amino acid biosynthetic pathways in a preclinical model of pancreatic ductal adenocarcinoma15
Comparative polar and lipid plasma metabolomics differentiate KSHV infection and disease states15
Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles15
Phosphoproteomics revealed cellular signals immediately responding to disruption of cancer amino acid homeostasis induced by inhibition of l-type amino acid transporter 114
Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma14
Lactate metabolism in clonal plasma cells and its therapeutic implications in multiple myeloma patients with elevated serum LDH levels14
Correction: STEAP4 inhibits cisplatin-induced chemotherapy resistance through suppressing PI3K/AKT in hepatocellular carcinoma14
Altered acetyl-CoA metabolism presents a new potential immunotherapy target in the obese lung microenvironment14
BMP4 upregulates glycogen synthesis through the SMAD/SLC2A1 (GLUT1) signaling axis in hepatocellular carcinoma (HCC) cells14
STEAP4 inhibits cisplatin-induced chemotherapy resistance through suppressing PI3K/AKT in hepatocellular carcinoma13
Loss of hexokinase 1 sensitizes ovarian cancer to high-dose metformin12
Statin use as a moderator on the association between metformin and breast cancer risk in women with type 2 diabetes mellitus12
Brief report: The uricase mutation in humans increases our risk for cancer growth12
Breast cancer cells that preferentially metastasize to lung or bone are more glycolytic, synthesize serine at greater rates, and consume less ATP and NADPH than parent MDA-MB-231 cells12
Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation12
Positron emission tomography imaging of the sodium iodide symporter senses real-time energy stress in vivo11
Dynamic regulation of mitochondrial pyruvate metabolism is necessary for orthotopic pancreatic tumor growth11
Carboxylesterase 1-mediated endocannabinoid metabolism in skin: role in melanoma progression in BRafV600E/Pten−/− mice10
RHOF promotes Snail1 lactylation by enhancing PKM2-mediated glycolysis to induce pancreatic cancer cell endothelial–mesenchymal transition10
METTL16 regulates the mRNA stability of FBXO5 via m6A modification to facilitate the malignant behavior of breast cancer10
Inhibition of glycolysis and mitochondrial respiration promotes radiosensitisation of neuroblastoma and glioma cells9
Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas8
A HIF-1α inhibitor combined with palmitic acid and L-carnitine treatment can prevent the fat metabolic reprogramming under hypoxia and induce apoptosis in hepatocellular carcinoma cells8
Glutaminolysis is associated with mitochondrial pathway activation and can be therapeutically targeted in glioblastoma8
Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer7
Phosphatidylinositol promoted the proliferation and invasion of pituitary adenoma cells by regulating POU1F1 expression7
Glucagon signaling via supraphysiologic GCGR can reduce cell viability without stimulating gluconeogenic gene expression in liver cancer cells7
Exploratory profiling of metabolites in cerebrospinal fluid using a commercially available targeted LC-MS based metabolomics kit to discriminate leptomeningeal metastasis6
Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia6
CD36 inhibition enhances the anti-proliferative effects of PI3K inhibitors in PTEN-loss anti-HER2 resistant breast cancer cells6
PDK1- and PDK2-mediated metabolic reprogramming contributes to the TGFβ1-promoted stem-like properties in head and neck cancer6
Computed tomography-measured body composition and survival in rectal cancer patients: a Swedish cohort study6
Metabolic flux analysis of 3D spheroids reveals significant differences in glucose metabolism from matched 2D cultures of colorectal cancer and pancreatic ductal adenocarcinoma cell lines6
Sulfatide imaging identifies tumor cells in colorectal cancer peritoneal metastases6
The effect of metabolic syndrome on head and neck cancer incidence risk: a population-based prospective cohort study6
Unraveling the glycosphingolipid metabolism by leveraging transcriptome-weighted network analysis on neuroblastic tumors5
Metabolic alterations and cellular responses to β-Hydroxybutyrate treatment in breast cancer cells5
Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells5
Breast cancer growth and proliferation is suppressed by the mitochondrial targeted furazano[3,4-b]pyrazine BAM155
GDF15-mediated enhancement of the Warburg effect sustains multiple myeloma growth via TGFβ signaling pathway5
Identification of novel lipid biomarkers in xmrk- and Myc-induced models of hepatocellular carcinoma in zebrafish4
Assessment of lipolysis biomarkers in adipose tissue of patients with gastrointestinal cancer4
Silencing of STEAP3 suppresses cervical cancer cell proliferation and migration via JAK/STAT3 signaling pathway4
High-fat diet promotes prostate cancer metastasis via RPS274
Serine starvation suppresses the progression of esophageal cancer by regulating the synthesis of purine nucleotides and NADPH4
The polyunsaturated fatty acid docosahexaenoic affects mitochondrial function in prostate cancer cells4
0.034033060073853